top of page

L'Oréal Introduces Melasyl: A Breakthrough Solution for Skin Pigmentation

L’Oréal Groupe today announced the launch of MelasylTM, a breakthrough molecule designed to address localized pigmentation issues that lead to age spots and post-acne marks. According to a landmark, worldwide epidemiological study on pigmentary disorders, half of all people report having at least one skin pigmentation issue1. L’Oréal formulations containing the new proprietary ingredient work inclusively, across all skin tones, to address pigmented marks on the skin and improve their appearance. Melasyl is the result of rigorous tests involving 121 scientific studies.

 


Cosmetic products formulated with multi-patented Melasyl help provide a more even, natural skin tone, addressing even the most persistent marks. Eighteen years of research have culminated in the introduction of Melasyl, which is now available in La Roche Posay’s Mela B3 franchise, including MelaB3 serum and MelaB3 SPF30. L’Oréal Paris and Vichy will follow with future product launches, expanding consumer access to expert formulations containing the new ingredient. 


“With half of all people reporting skin pigmentation issues and a third of these experiencing lower quality of life as a result, the impact of visible spots or post-acne marks is clearly more than skin-deep,” said Anne Colonna, Global Head of Advanced Research at L’Oréal Groupe. “Melasyl is a first-of-its kind ingredient that helps to address localized skin pigmentation issues, with proven efficacy and wide accessibility that will enable more people to regain their selfconfidence.”Melanin enables the vast spectrum of human skin tones in all their diversity, with melanin production increasing following sun exposure to protect skin cells. Many factors can upset normal melanin production, which can lead to localized pigmentation issues such as age spots and post-inflammatory marks. L’Oréal formulations containing Melasyl improve the appearance of existing dark spots, including persistent ones, with clinically demonstrated efficacy and safety across all skin tones.



For over a century, L’Oréal has been a leader in advanced sciences for beauty, with 35 years of dedicated research into skin pigmentation. Melasyl was first presented at the World Congress of Dermatology 2023 in Singapore, alongside the first worldwide epidemiological study on pigmentary disorders. Melasyl was recently featured at the American Academy of Dermatology’s annual meeting in San Diego from March 8-12, 2024. 


By ML Staff. Image courtesy of L’Oréal

Comments


bottom of page